Us Manufacturing Ism

Nov 25, 2015 at 11:28 | Source: CNBC
Introduced in September 2014, Make in India is Prime Minister Narendra Modi's ambitious initiative to transform India into a global manufacturing powerhouse a field dominated by China over the past three decades.
Nov 21, 2015 at 16:01 | Source: Reuters
The settlement between a US unit of Swiss drugmaker Novartis AG, the federal government and more than 40 states concerns payments that the drug manufacturer paid between 2007 and 2012 to certain specialty pharmacies to entice them to recommend prescriptions to Medicaid and Medicare patients.
Nov 21, 2015 at 12:26 | Source:
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Sildenafil Tablets, 20 mg (ANDA 203963). This product is expected to be launched by Q4 FY 2015-16.
Nov 17, 2015 at 17:00 | Source: CNBC-TV18
Cerebra Integrated Technologies has signed a Memorandum of Understanding (MoU) with US-based Echostreams for manufacturing cold storage servers and other storage products.
Nov 10, 2015 at 08:40 | Source: Reuters
The US company will also invest USD 200 million to build local manufacturing and service facilities, GE said in a statement on Monday.
Nov 09, 2015 at 18:40 | Source: PTI
Dr Reddy's CEO G V Prasad said the company is in the process of shifting some of the products to other plants in the wake of warning letters. r
Nov 06, 2015 at 11:10 | Source: Reuters
The warning letter was issued by the FDA to Dr Reddy's on Thursday for its Srikakulam, Miryalaguda and Duvvada drug manufacturing plants - all based in southern India.
Nov 02, 2015 at 21:50 | Source: Reuters
Other data on Monday showed construction spending rose in September, indicating the economy remained on firmer ground despite some cooling in consumer spending and persistent weakness in manufacturing.
Oct 23, 2015 at 11:22 | Source:
This is the 50th ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for manufacturing Oral Non-Antibiotic products.
Oct 23, 2015 at 10:40 | Source:
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Tramadol Hydrochloride Extendedrelease Tablets USP, 100 mg, 200 mg and 300 mg (ANDA 204421). This product will be launched by Q4 FY 2015-16.
Explore Moneycontrol

Copyright © Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of is prohibited.